dndi astmh 2014

2
DNDi @ ASTMH 2014 Drugs for Neglected Diseases initiative (DNDi ) presentations at the American Society of Tropical Medicine and Hygiene (ASTMH), 63rd Annual Meeting NOVEMBER 2-6, 2014 Sheraton New Orleans Hotel and New Orleans Marriott Hotel New Orleans, LA

Upload: others

Post on 29-Nov-2021

5 views

Category:

Documents


0 download

TRANSCRIPT

DNDi @ ASTMH 2014Drugs for Neglected Diseases initiative (DNDi ) presentations

at the American Society of Tropical Medicine and Hygiene (ASTMH), 63rd Annual Meeting

NoveMber 2-6, 2014

Sheraton New Orleans Hotel and New Orleans Marriott Hotel

New orleans, LA

Drugs for Neglected Diseases initiative, North America40 Wall Street, 24th Floor – New York, NY 10005Telephone: +1.646.616.8680Email: [email protected]

www.dndi.org

Follow us!Facebook: facebook.com/dndi.org

Twitter: @DNDi_HQ

Drugs for Neglected Diseases initiative (DNDi) American Society of Tropical Medicine and Hygiene (ASTMH)

NoveMber 2-6, 2014 • New orLeANS http://bit.ly/DNDiASTMH2014

Visit us at the DNDi Booth! #307

DNDi @ ASTMH 2014

Monday, November 3rd, 2014

> POSTER (498)Oral flubendazole: a potentially useful macrofilaricide• DNDi Author: Ivan Scandale• Session title: 28: Poster Session A • Session time: 12:00 -1:45 PM• Location: New Orleans Marriott

Grand Ballroom, 3rd Floor

> SIDE EVENTChanging the face of chagas disease• Event time: 6:00 PM• Location (OFF SITE): Tulane

University School of Public Health and Tropical Medicine, Collins C. Diboll Gallery & Auditorium, 1440 Canal Street

• Sponsors: Sabin Vaccine Institute, the National School of Tropical Medicine at Baylor College of Medicine, DNDi, MSF, the Global Chagas Disease Coalition, ASTMH and PAHO

• Link: http://bit.ly/FaceOfChagas

Tuesday, November 4th, 2014

> ORAL (1483)Efficacy, safety and population pharmacokinetics of the artesunate mefloquine (ASMQ) fixed dose combination versus artemether lumefantrine for the treatment of uncomplicated falciparum malaria in African children

• DNDi Authors: Joelle Vanraes, Nathalie Strub-Wourgaft, Gwenaelle Carn

• Session title: 64: Malaria: Drug Development - New Approaches, Efficacy, Safety and Pharmacology

• Session time: 8:00 - 9:45 AM• Location: Sheraton New Orleans

Grand Ballroom D, 5th Floor

> ORAL (1209)Drug discovery and development for the treatment and control of filariasis: repurposing emodepside• DNDi Authors: Robert Don,

Ivan Scandale• Session title: 108: Filariasis:

Clinical• Session time: 4:00 - 5:45 PM• Location: New Orleans Marriott

Mardi Gras Ballroom D, 3rd Floor

Wednesday, November 5th, 2014

> POSTER (1459)The AMFm in Ghana: factors associated with private retailers: adherence to the recommended retail price• DNDi Author: Graciela Diap• Session title: 140: Poster

Session C• Session time: 12:00 - 1:45 PM• Location: New Orleans Marriott

Grand Ballroom, 3rd Floor

> SyMPOSIuM (153)New treatments for kinetoplastid diseases

that can be easily delivered in rural health posts: where are we now?• DNDi Presenter: Nathalie

Strub-Wourgaft• Session title: Transitioning from

the vertical to the horizontal: Challenges in integrating diagnosis and treatment of kinetoplastid diseases in essential health services

• Session time: 1:45 - 3:30 PM• Location: New Orleans Marriott

Mardi Gras Ballroom D, 3rd Floor

> SyMPOSIuM (64)Towards the elimination of human African trypanosomiasis (HAT)• Details: Chair: Jose Ramon

Franco Minguell (WHO); Co-chair: Crispin Lumbala (PNLTHA)

4:00 PM Veerle Lejon (IRD): Advances and challenges in current diagnostics for HAT

4:20 PM Antoine Tarral (DNDi ): New oral treatments for HAT

4:40 PM Wilfried Mutombo (PNLTHA): Implementation of studies in remote areas in countries with limited regulatory and ethics experience

5:00 PM Jose Ramon Franco Minguell (WHO): How to achieve HAT elimination with current and new tools

• Session time: 4:00 - 5:45 PM• Location: New Orleans Marriott

Grand Ballroom FGH, 3rd Floor